{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:40:41Z","timestamp":1761986441027},"reference-count":26,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2007,2,8]],"date-time":"2007-02-08T00:00:00Z","timestamp":1170892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[2007,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The identification of a safe and reliable alternative for patients with non\u2010steroidal anti\u2010inflammatory drug (NSAID)\u2010induced urticaria\/angioedema is a frequent problem for dermatologists and other practitioners. Cyclooxygenase\u20102 (COX\u20102) inhibitors have been reported to be safe for NSAID\u2010intolerant patients from the US and Europe but not all of them have yet been approved for use in Japan. It was our objective to investigate the clinical manifestations of oral NSAID challenges in Japanese patients with histories of urticaria and\/or angioedema after the intake of NSAIDs and to find safe alternative drugs, including COX\u20102 inhibitors and a basic anti\u2010inflammatory drug. Twenty subjects suspected NSAID\u2010induced urticaria\/angioedema from histories were included in a double\u2010blind or single\u2010blind, placebo\u2010controlled oral challenge protocol using NSAIDs. Skin prick tests using NSAIDs, which were dissolved in saline, were conducted. The mean age of the patients was 37.3\u00a0years; 14 patients were female. The results of other challenge tests showed that the most frequently intolerated drugs was loxoprofen (100%), followed by acetyl salicylic (94.4%), etodolac (53.3%), dicrofenac (50%), acetaminophen (38.5%), meloxicam (3<jats:italic>3<\/jats:italic>%), and tiaramide (21.4%). Urticaria and angioedema were induced after aspirin intake in 83.3% and 22.2% of patients, respectively, whereas an asthmatic response was seen in 5.6%. Skin prick tests with NSAIDs were 100% negative. This study showed that among the NSAIDs that are available in Japan and that were investigated in this study, tiaramide, which does not inhibit COX, is the relatively safe alternative drug for Japanese patients with NSAID\u2010induced urtiacaria and\/or angioedema. Furthermore, meloxicam seems to be better tolerated than etodolac between two selective COX\u20102 inhibitors.<\/jats:p>","DOI":"10.1111\/j.1346-8138.2007.00244.x","type":"journal-article","created":{"date-parts":[[2007,2,8]],"date-time":"2007-02-08T09:32:21Z","timestamp":1170927141000},"page":"172-177","source":"Crossref","is-referenced-by-count":8,"title":["Safety of selective cyclooxygenase\u20102 inhibitors and a basic non\u2010steroidal anti\u2010inflammatory drug (NSAID) in Japanese patients with NSAID\u2010induced urticaria and\/or angioedema: Comparison of meloxicam, etodolac and tiaramide"],"prefix":"10.1111","volume":"34","author":[{"given":"Naoko","family":"INOMATA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"OSUNA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"YAMAGUCHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"ONODA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"TAKESHITA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"CHIBA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"KAMBARA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenro","family":"IKEZAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,2,8]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(77)90106-3"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.1487"},{"key":"e_1_2_5_4_2","first-page":"215","article-title":"Tolerability of three selective cyclo\u2010oxygenase\u20102 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID\u2010sensitive patients","volume":"36","author":"Senna G","year":"2004","journal-title":"Allerg Immunol (Paris)"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.12.1577"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)61282-3"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2002.01260.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.55.203"},{"issue":"10","key":"e_1_2_5_9_2","first-page":"22","article-title":"Skin tests used in type I allergy testing. Position paper","volume":"44","author":"Dreborg S","year":"1989","journal-title":"Allergy"},{"key":"e_1_2_5_10_2","first-page":"66","article-title":"Autologous serum skin test for chronic urticaria","volume":"58","author":"Hide M","year":"2004","journal-title":"Jpn J Clin Dermatol"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.3.5.471"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62221-1"},{"key":"e_1_2_5_13_2","first-page":"169","volume-title":"Allergy. Principles Pract","author":"Stevenson DD","year":"2003"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199300461-00065"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)63166-3"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62748-2"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1081\/IPH-100107335"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1998.tb03854.x"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62412-X"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62226-0"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2001.056008803.x"},{"key":"e_1_2_5_22_2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2174\/1568005310101030233","article-title":"Update on sensitivity to nonsteroidal antiinflammatory drugs","volume":"1","author":"Nettis E","year":"2001","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2005.2228.x"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.163"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.12.323"},{"key":"e_1_2_5_26_2","first-page":"385","article-title":"Consensus Conference: management of chronic urticaria. Wednesday 8 January 2003. Institute Pasteur\u2010Paris, France. Recommendation (short version)","volume":"13","author":"Societe Francaise de Dermatologie","year":"2003","journal-title":"Eur J Dermatol"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62384-8"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1346-8138.2007.00244.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1346-8138.2007.00244.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T18:55:12Z","timestamp":1697223312000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1346-8138.2007.00244.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,8]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["10.1111\/j.1346-8138.2007.00244.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1346-8138.2007.00244.x","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"value":"0385-2407","type":"print"},{"value":"1346-8138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,8]]}}}